Article
Pulsed priming with the FAK inhibitor narmafotinib enhances both gemcitabine/Abraxane and FOLFIRINOX chemotherapy response in pancreatic cancer
2026-07-23
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Pancreatic ductal adenocarcinoma (PDAC) is a particularly lethal malignancy with few treatment options available. Extensive remodelling of extracellular matrix (ECM) generates a highly fibrotic tumour landscape, which impairs therapeutic response. <h4>Objective</h4> We investigated whether stromal priming via the highly specific Focal Adhesion Kinase (FAK) inhibitor narmaf...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cf9d1702-eda9-5061-a22d-728ae53e3e4f
- DOI
- 10.64898/2026.07.23.740234
